Molecular characterization of respiratory syncytial viruses infecting children reported to have received palivizumab immunoprophylaxis
Danielle Bruna Leal Oliveira(Centers for Disease Control and Prevention), Dean D. Erdman(University College Dublin), Edison Luíz Durigon(Universidade de São Paulo), Geoffrey A. Weinberg(University of Rochester), Marika K. Iwane(National Center for Immunization and Respiratory Diseases), Peter G. Szilagyi(University of California, Los Angeles), Kathryn M. Edwards(Vanderbilt University Medical Center), Mary Allen Staat, John V. Williams(University of Wisconsin–Madison), Mila M. Prill(Department of Human Services), Caroline Breese Hall(Bio Products Laboratory (United Kingdom)), Marie R. Griffin(Vanderbilt University)
Cited by 29
Related Papers
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
|New England Journal of Medicine|2003|4.5k
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
|New England Journal of Medicine|2015|3.4k
Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
|Science|2003|2.6k
The Burden of Respiratory Syncytial Virus Infection in Young Children
|New England Journal of Medicine|2009|2.3k
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Children
|New England Journal of Medicine|2015|1.9k